The last subtype of CRC may develop from both conventional adenoma and sessile serrated adenoma, includes about 20% of tumors, and is characterized by CIN, CIMP-L, MSS, or MSI-L due to MGMT methylation, and always KRAS mutations (6). The gene discussed is KRAS; the disease is adenoma.